Growth Metrics

LifeStance Health (LFST) Receivables - Net (2021 - 2025)

LifeStance Health (LFST) has disclosed Receivables - Net for 5 consecutive years, with $95.7 million as the latest value for Q4 2025.

  • Quarterly Receivables - Net fell 27.38% to $95.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $95.7 million through Dec 2025, down 27.38% year-over-year, with the annual reading at $95.7 million for FY2025, 27.38% down from the prior year.
  • Receivables - Net for Q4 2025 was $95.7 million at LifeStance Health, down from $121.1 million in the prior quarter.
  • The five-year high for Receivables - Net was $175.9 million in Q1 2024, with the low at $60.1 million in Q2 2021.
  • Average Receivables - Net over 5 years is $118.4 million, with a median of $121.1 million recorded in 2025.
  • The sharpest move saw Receivables - Net soared 66.04% in 2022, then dropped 27.38% in 2025.
  • Over 5 years, Receivables - Net stood at $76.1 million in 2021, then soared by 32.58% to $100.9 million in 2022, then rose by 24.33% to $125.4 million in 2023, then grew by 5.1% to $131.8 million in 2024, then decreased by 27.38% to $95.7 million in 2025.
  • According to Business Quant data, Receivables - Net over the past three periods came in at $95.7 million, $121.1 million, and $129.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.